Microscopic-Observation Drug-Susceptibility Assay for the Diagnosis of Drug-Resistant Tuberculosis in Harare, Zimbabwe

被引:20
|
作者
Makamure, Beauty [1 ]
Mhaka, Jesca [1 ]
Makumbirofa, Salome [1 ]
Mutetwa, Reggie [1 ]
Mupfumi, Lucy [1 ]
Mason, Peter [1 ,2 ]
Metcalfe, John Z. [3 ]
机构
[1] Biomed Res & Training Inst, Harare, Zimbabwe
[2] Univ Zimbabwe, Coll Hlth Sci, Harare, Zimbabwe
[3] Univ Calif San Francisco, San Francisco Gen Hosp, Div Pulm & Crit Care Med, Francis J Curry Int TB Ctr, San Francisco, CA 94143 USA
来源
PLOS ONE | 2013年 / 8卷 / 02期
基金
美国国家卫生研究院;
关键词
MULTIDRUG-RESISTANT; PREVALENCE; CULTURE; AFRICA; TRIAL;
D O I
10.1371/journal.pone.0055872
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Introduction: Limited data exist on use of the microscopic-observation drug-susceptibility (MODS) assay among persons suspected of MDR-TB living in high HIV-prevalence settings. Methods: We retrospectively reviewed available clinical and drug susceptibility data for drug-resistant TB suspects referred for culture and drug-susceptibility testing between April 1, 2011 and March 1, 2012. The diagnostic accuracy of MODS was estimated against a reference standard including Lowenstein-Jensen (LJ) media and manual liquid (BACTEC MGIT) culture. The accuracy of MODS drug-susceptibility testing (DST) was assessed against a reference standard absolute concentration method. Results: One hundred thirty-eight sputum samples were collected from 99 drug-resistant TB suspects; in addition, six previously cultured MDR isolates were included for assessment of DST accuracy. Among persons with known HIV infection status, 39/59 (66%) were HIV-infected. Eighty-six percent of patients had a history of prior TB treatment, and 80% of individuals were on antituberculous treatment at the time of sample collection. M. tuberculosis was identified by reference standard culture among 34/98 (35%) MDR-TB suspects. Overall MODS sensitivity for M. tuberculosis detection was 85% (95% CI, 69-95%) and specificity was 93% (95% CI, 84-98%); diagnostic accuracy did not significantly differ by HIV infection status. Median time to positivity was significantly shorter for MODS (7 days; IQR 7-15 days) than MGIT (12 days; IQR 6-16 days) or LJ (28 days; IQR 21-35 days; p < 0.001). Of 33 specimens with concurrent DST results, sensitivity of the MODS assay for detection of resistance to isoniazid, rifampin, and MDR-TB was 88% (95% CI, 68-97%), 96% (95% CI, 79-100%), and 91% (95% CI, 72-99%), respectively; specificity was 89% (95% CI, 52-100%), 89% (95% CI, 52-100%), and 90% (95% CI, 56-100%), respectively. Conclusion: In a high HIV-prevalence setting, MODS diagnosed TB and drug-resistant TB with high sensitivity and shorter turnaround time compared with standard culture and DST methods.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Expanding the Role of the Microscopic Observation Drug Susceptibility Assay in Tuberculosis and HIV Management
    Minion, Jessica
    Pai, Madhukar
    CLINICAL INFECTIOUS DISEASES, 2010, 50 (07) : 997 - 999
  • [32] Shedding light on the performance of a pyrosequencing assay for drug-resistant tuberculosis diagnosis
    Sophia B. Georghiou
    Marva Seifert
    Shou-Yean Lin
    Donald Catanzaro
    Richard S. Garfein
    Roberta L. Jackson
    Valeriu Crudu
    Camilla Rodrigues
    Thomas C. Victor
    Antonino Catanzaro
    Timothy C. Rodwell
    BMC Infectious Diseases, 16
  • [33] Molecular Drug-Susceptibility Test for Tuberculosis
    Maitre, Thomas
    Aubry, Alexandra
    Veziris, Nicolas
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (24): : 2403 - 2404
  • [34] Shedding light on the performance of a pyrosequencing assay for drug-resistant tuberculosis diagnosis
    Georghiou, Sophia B.
    Seifert, Marva
    Lin, Shou-Yean
    Catanzaro, Donald
    Garfein, Richard S.
    Jackson, Roberta L.
    Crudu, Valeriu
    Rodrigues, Camilla
    Victor, Thomas C.
    Catanzaro, Antonino
    Rodwell, Timothy C.
    BMC INFECTIOUS DISEASES, 2016, 16
  • [35] Drug-Resistant Tuberculosis in High-Risk Groups, Zimbabwe
    Metcalfe, John Z.
    Makumbirofa, Salome
    Makamure, Beauty
    Sandy, Charles
    Bara, Wilbert
    Mungofa, Stanley
    Hopewell, Philip C.
    Mason, Peter
    EMERGING INFECTIOUS DISEASES, 2014, 20 (01) : 135 - 137
  • [36] A suggested algorithm for detection of multi drug-resistant tuberculosis in Zimbabwe
    Makamure, Beauty
    Makumbirofa, Salome
    Bandason, Tsitsi
    Leccese, Paul
    Mutetwa, Reggie
    Robertson, Val
    Mason, Peter
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2017, 11 (08): : 611 - 618
  • [37] Drug-resistant tuberculosis: advances in diagnosis and management
    Guenther, Gunar
    Ruswa, Nunurai
    Keller, Peter M.
    CURRENT OPINION IN PULMONARY MEDICINE, 2022, 28 (03) : 211 - 217
  • [38] DIAGNOSIS AND TREATMENT OF DRUG-RESISTANT TUBERCULOSIS IN CHILDREN
    Seddon, Doctor James Alexander
    PEDIATRIC PULMONOLOGY, 2015, 50 : S23 - S24
  • [39] Pulmonary tuberculosis misdiagnosed as extensively drug-resistant tuberculosis due to selection of a nontuberculous mycobacterial colony from a preculture dish used for a drug-susceptibility test
    Ohji, Reina
    Shinohara, Tsutomu
    Ohji, Hiroshi
    Hatakeyama, Nobuo
    Iwamura, Sachiko
    Ogushi, Fumitaka
    RESPIRATORY INVESTIGATION, 2020, 58 (03) : 216 - 219
  • [40] Recent developments in the diagnosis of drug-resistant tuberculosis
    Nicol, Mark P.
    Cox, Helen
    MICROBIOLOGY AUSTRALIA, 2019, 40 (02) : 82 - 86